Cargando…
Cohort profile: Actionable Register of Geneva Outpatients and inpatients with SARS-CoV-2 (ARGOS)
PURPOSE: The Actionable Register of Geneva Outpatients and inpatients with SARS-CoV-2 (ARGOS) is an ongoing prospective cohort created by the Geneva Directorate of Health. It consists of an operational database compiling all SARS-CoV-2 test results recorded in the Geneva area since late February 202...
Autores principales: | , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8634627/ https://www.ncbi.nlm.nih.gov/pubmed/34848509 http://dx.doi.org/10.1136/bmjopen-2021-048946 |
_version_ | 1784608158276124672 |
---|---|
author | Genecand, Camille Mongin, Denis Koegler, Flora Lebowitz, Dan Regard, Simon Falcone, Jean-Luc Nehme, Mayssam Braillard, Olivia Grira, Marwène Joubert, Dominique Chopard, Pierre Delaporte, Elisabeth Stirnemann, Jérôme Guessous, Idris Tardin, Aglaé Courvoisier, Delphine S |
author_facet | Genecand, Camille Mongin, Denis Koegler, Flora Lebowitz, Dan Regard, Simon Falcone, Jean-Luc Nehme, Mayssam Braillard, Olivia Grira, Marwène Joubert, Dominique Chopard, Pierre Delaporte, Elisabeth Stirnemann, Jérôme Guessous, Idris Tardin, Aglaé Courvoisier, Delphine S |
author_sort | Genecand, Camille |
collection | PubMed |
description | PURPOSE: The Actionable Register of Geneva Outpatients and inpatients with SARS-CoV-2 (ARGOS) is an ongoing prospective cohort created by the Geneva Directorate of Health. It consists of an operational database compiling all SARS-CoV-2 test results recorded in the Geneva area since late February 2020. This article aims at presenting this comprehensive cohort, in light of some of the varying public health measures in Geneva, Switzerland, since March 2020. PARTICIPANTS: As of 1 June 2021, the database included 360 525 patients, among which 65 475 had at least one positive test result for SARS-CoV-2. Among all positive patients, 37.6% were contacted only once, 10.6% had one follow-up call, 8.5% had two and 27.7% had three or more follow-up calls. Participation rate among positive patients is 94%. Data collection is ongoing. FINDINGS TO DATE: ARGOS data illustrates the magnitude of COVID-19 pandemic in Geneva, Switzerland, and details a variety of population factors and outcomes. The content of the cohort includes demographic data, comorbidities and risk factors for poor clinical outcome, self-reported COVID-19 symptoms, environmental and socioeconomic factors, prospective and retrospective contact tracing data, travel quarantine data and deaths. The registry has already been used in several publications focusing on symptoms and long COVID-19, infection fatality rate and re-infection. FUTURE PLANS: The data of this large real-world registry provides a valuable resource for various types of research, such as clinical research, epidemiological research or policy assessment as it illustrates the impact of public health policies and overall disease burden of COVID-19. |
format | Online Article Text |
id | pubmed-8634627 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | BMJ Publishing Group |
record_format | MEDLINE/PubMed |
spelling | pubmed-86346272021-12-01 Cohort profile: Actionable Register of Geneva Outpatients and inpatients with SARS-CoV-2 (ARGOS) Genecand, Camille Mongin, Denis Koegler, Flora Lebowitz, Dan Regard, Simon Falcone, Jean-Luc Nehme, Mayssam Braillard, Olivia Grira, Marwène Joubert, Dominique Chopard, Pierre Delaporte, Elisabeth Stirnemann, Jérôme Guessous, Idris Tardin, Aglaé Courvoisier, Delphine S BMJ Open Epidemiology PURPOSE: The Actionable Register of Geneva Outpatients and inpatients with SARS-CoV-2 (ARGOS) is an ongoing prospective cohort created by the Geneva Directorate of Health. It consists of an operational database compiling all SARS-CoV-2 test results recorded in the Geneva area since late February 2020. This article aims at presenting this comprehensive cohort, in light of some of the varying public health measures in Geneva, Switzerland, since March 2020. PARTICIPANTS: As of 1 June 2021, the database included 360 525 patients, among which 65 475 had at least one positive test result for SARS-CoV-2. Among all positive patients, 37.6% were contacted only once, 10.6% had one follow-up call, 8.5% had two and 27.7% had three or more follow-up calls. Participation rate among positive patients is 94%. Data collection is ongoing. FINDINGS TO DATE: ARGOS data illustrates the magnitude of COVID-19 pandemic in Geneva, Switzerland, and details a variety of population factors and outcomes. The content of the cohort includes demographic data, comorbidities and risk factors for poor clinical outcome, self-reported COVID-19 symptoms, environmental and socioeconomic factors, prospective and retrospective contact tracing data, travel quarantine data and deaths. The registry has already been used in several publications focusing on symptoms and long COVID-19, infection fatality rate and re-infection. FUTURE PLANS: The data of this large real-world registry provides a valuable resource for various types of research, such as clinical research, epidemiological research or policy assessment as it illustrates the impact of public health policies and overall disease burden of COVID-19. BMJ Publishing Group 2021-11-30 /pmc/articles/PMC8634627/ /pubmed/34848509 http://dx.doi.org/10.1136/bmjopen-2021-048946 Text en © Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. https://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) . |
spellingShingle | Epidemiology Genecand, Camille Mongin, Denis Koegler, Flora Lebowitz, Dan Regard, Simon Falcone, Jean-Luc Nehme, Mayssam Braillard, Olivia Grira, Marwène Joubert, Dominique Chopard, Pierre Delaporte, Elisabeth Stirnemann, Jérôme Guessous, Idris Tardin, Aglaé Courvoisier, Delphine S Cohort profile: Actionable Register of Geneva Outpatients and inpatients with SARS-CoV-2 (ARGOS) |
title | Cohort profile: Actionable Register of Geneva Outpatients and inpatients with SARS-CoV-2 (ARGOS) |
title_full | Cohort profile: Actionable Register of Geneva Outpatients and inpatients with SARS-CoV-2 (ARGOS) |
title_fullStr | Cohort profile: Actionable Register of Geneva Outpatients and inpatients with SARS-CoV-2 (ARGOS) |
title_full_unstemmed | Cohort profile: Actionable Register of Geneva Outpatients and inpatients with SARS-CoV-2 (ARGOS) |
title_short | Cohort profile: Actionable Register of Geneva Outpatients and inpatients with SARS-CoV-2 (ARGOS) |
title_sort | cohort profile: actionable register of geneva outpatients and inpatients with sars-cov-2 (argos) |
topic | Epidemiology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8634627/ https://www.ncbi.nlm.nih.gov/pubmed/34848509 http://dx.doi.org/10.1136/bmjopen-2021-048946 |
work_keys_str_mv | AT genecandcamille cohortprofileactionableregisterofgenevaoutpatientsandinpatientswithsarscov2argos AT mongindenis cohortprofileactionableregisterofgenevaoutpatientsandinpatientswithsarscov2argos AT koeglerflora cohortprofileactionableregisterofgenevaoutpatientsandinpatientswithsarscov2argos AT lebowitzdan cohortprofileactionableregisterofgenevaoutpatientsandinpatientswithsarscov2argos AT regardsimon cohortprofileactionableregisterofgenevaoutpatientsandinpatientswithsarscov2argos AT falconejeanluc cohortprofileactionableregisterofgenevaoutpatientsandinpatientswithsarscov2argos AT nehmemayssam cohortprofileactionableregisterofgenevaoutpatientsandinpatientswithsarscov2argos AT braillardolivia cohortprofileactionableregisterofgenevaoutpatientsandinpatientswithsarscov2argos AT griramarwene cohortprofileactionableregisterofgenevaoutpatientsandinpatientswithsarscov2argos AT joubertdominique cohortprofileactionableregisterofgenevaoutpatientsandinpatientswithsarscov2argos AT chopardpierre cohortprofileactionableregisterofgenevaoutpatientsandinpatientswithsarscov2argos AT delaporteelisabeth cohortprofileactionableregisterofgenevaoutpatientsandinpatientswithsarscov2argos AT stirnemannjerome cohortprofileactionableregisterofgenevaoutpatientsandinpatientswithsarscov2argos AT guessousidris cohortprofileactionableregisterofgenevaoutpatientsandinpatientswithsarscov2argos AT tardinaglae cohortprofileactionableregisterofgenevaoutpatientsandinpatientswithsarscov2argos AT courvoisierdelphines cohortprofileactionableregisterofgenevaoutpatientsandinpatientswithsarscov2argos |